Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Schizophrenia Health Center

Font Size

New Schizophrenia Drug Shows Promise

Experimental Drug May Be New Way to Treat Schizophrenia
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 4, 2007 -- An experimental new drug may prove to be new way to treat schizophrenia, new research shows.

A study published in the advance online edition of the journal Nature Medicine highlights the new schizophrenia drug, which doesn't have a catchy name yet.

The drug, which is being developed by the drug company Eli Lilly, is currently called "LY2140023." That name refers to the drug's chemical structure.

Lilly scientists tested LY2140023 on nearly 200 adults with schizophrenia in Russian mental institutions.

The patients had been hospitalized for worsening symptoms. They were 40 years old, on average, and typically had had schizophrenia for more than 15 years, according to the study.

During the four-week study, patients either took two daily pills containing LY2140023, a daily shot of the antipsychotic drug olanzapine, or a pill containing no medicine (placebo).

Patients taking LY2140023 or olanzapine had a reduction in their schizophrenia symptoms, compared to patients taking the placebo.

Overall, the new schizophrenia drug was "safe and well tolerated," the study states. Side effects were typically mild to moderate and included insomnia, nausea, and headache.

In addition, patients taking LY2140023 "seemed to be more emotional than before," write the researchers, who included Sandeep Patil, MD, PhD, who now works for Takeda Pharmaceutical Company.

LY2140023 has antipsychotic effects but works differently than other antipsychotic drugs, targeting a brain chemical called glutamate, which has long been suspected of playing a role in schizophrenia, note the researchers.

They call for longer, larger studies to test LY2140023 as a new schizophrenia medication.

Today on WebMD

Mental Health Psychotic Disorders
Schizophrenia Medications
bored man resting chin on hands
vincent van gogh
Schizophrenia What Increases Your Risk
mother and daughter
boy hiding under blanket
male patient with doctor
romantic couple
businesswoman working at desk at night